We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
132 hedge funds and large institutions have $219M invested in Esperion Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
328% more call options, than puts
Call options by funds: $10.3M | Put options by funds: $2.4M
188% more capital invested
Capital invested by funds: $75.9M → $219M (+$143M)
55% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 20
8% more funds holding
Funds holding: 122 → 132 (+10)
3% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 35
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less ownership
Funds ownership: 72.23% → 64.23% (-8%)
Holders
132
Holders Change
+10
Holders Change %
+8.2%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
36
Reduced
35
Closed
20
Calls
$10.3M
Puts
$2.4M
Net Calls
+$7.87M
Net Calls Change
+$6.54M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$4.15M |
| 2 |
Renaissance Technologies
New York
|
+$1.57M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.57M |
| 4 |
WCM
Whitefort Capital Management
New York
|
+$1.15M |
| 5 |
Two Sigma Investments
New York
|
+$1.14M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.01M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.42M |
| 3 |
Millennium Management
New York
|
-$3.04M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.82M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.56M |
